✦ LIBER ✦

The syndrome of inappropriate antidiuretic hormone secretion associated with induction chemotherapy for squamous cell carcinoma of the head and neck

✍ Scribed by Daniel F. Hayes; Ronald M. Lechan; Marshall R. Posner; Ralph R. Weichselbaum; Daniel Miller; Thomas J. Ervin

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 268 KB
Volume: 32
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.2930320306

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Syndrome of inappropriate secretion of a

Syndrome of inappropriate secretion of antidiuretic hormone in a patient with carcinoma of the nasopharynx

✍ Brian D. Kavanagh; Edward C. Halperin; Gajanan Nilaver 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

Thyroid carcinoma associated with squamo

Thyroid carcinoma associated with squamous cell carcinoma of the head and neck: Which policy?

✍ Marco Guzzo; Pasquale Quattrone; Ettore Seregni; Roberto Bianchi; Franco Mattave 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

## Abstract ## Background Thyroid carcinoma occurring as a second primary associated with head and neck squamous cell carcinoma (HNSCC) is unusual. The clinical management of thyroid cancer in such cases has been debated. ## Methods Between 1975 and 2004, we collected 33 cases. The associated th

Ectopic atrial natriuretic peptide produ

Ectopic atrial natriuretic peptide production in small cell lung cancer with the syndrome of inappropriate antidiuretic hormone secretion

✍ K. Shimizu; S. Nakano; Y. Nakano; M. Ando; K. Seki; N. Kameda 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB 👁 2 views

Phase II study of induction chemotherapy

Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck

✍ Dong M. Shin; Bonnie S. Glisson; Fadlo R. Khuri; Scott M. Lippman; Lawrence Gins 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## Abstract ## BACKGROUND This Phase II trial was conducted to determine the response rate, particularly of the primary sites, tolerability, and toxicity of induction chemotherapy of paclitaxel, ifosfamide, and carboplatin for patients with previously untreated locally advanced squamous cell carci

Phase II study of induction chemotherapy

Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck

✍ Robert Haddad; Marshall Posner 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB 👁 2 views

Cost utility of docetaxel as induction c

Cost utility of docetaxel as induction chemotherapy followed by chemoradiation in locally advanced squamous cell carcinoma of the head and neck

✍ Anju Parthan; Marshall R. Posner; Caroline Brammer; Philippe Beltran; Jeroen P. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 1 views

## Abstract ## Background Trial TAX 324 showed that induction chemotherapy with docetaxel plus cisplatin and 5‐fluorouracil (TPF) compared with cisplatin and 5‐fluorouracil (PF) followed by chemoradiation increases survival and time to progression in squamous cell carcinoma of head and neck (SCCHN